CLINICAL AND EPIDEMIOLOGICAL FEATURES OF NOROVIRUS INFECTION IN PREGNANT WOMEN


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To study the clinical and epidemiological features of norovirus infection in pregnant women. Subjects and methods. Two hundred and fifty-one women were followed up in different periods of pregnancy, 65 (25.9%) patients were diagnosed as having norovirus infection. Most (45.8%) patients were 25-30 years old. The disease was diagnosed by fecal ELISA using the Ridascreen Norwalk-like virus test system. Results. The peak incidence of norovirus infection was recorded in January and February (27.3 and 35.8%, respectively). 48% of the pregnant women had been in contact with sick family members, more often with children. Clinically, there was a preponderance of the symptoms of gastroenteritis (95.8%) and poisoning (83.3%). The leading symptoms in relation to the severity and duration of the disease were diarrhea concomitant with nausea and vomiting (95.8 and 91.6%, respectively). 70.8% of the pregnant women had a moderate disease course. The pain syndrome was present in 62.5% of the patients, with epigastric pain being in 73.3% of cases. The catarrhal symptoms were much less common (29.2%), hemograms showed leukocytosis, neutrophilia, and accelerated erythrocyte sedimentation rate. The treatment included rehydration therapy, as well as probiotics (linex and lactobacterin). Conclusion. The comprehensive studies have shown that the clinical picture of the norovirus infection in pregnant women is not substantially different from that in other population groups.

Full Text

Restricted Access

About the authors

N. M GRACHEVA

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Email: leonteva-nina@yandex.ru
Moscow

N. A MALYSHEV

Infectious Diseases Hospital One, Moscow Healthcare Department

Moscow

A. A AVAKOV

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Moscow

O. S PARTIN

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Moscow

A. I SOLOVYEVA

G.N. Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare

Moscow

N. R SHAKARYAN

Infectious Diseases Hospital One, Moscow Healthcare Department

Moscow

References

  1. Постановление Главного государственного санитарного врача РФ от 19 марта 2010 г. № 21 «О профилактике острых кишечных инфекций». М., 2010.
  2. Mattner E., Sohr D., Hein A. et al. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Сlin. Microbiol. Infect. 2006; 12(1): 69-74.
  3. Михайлова Е.В., Салов И.А., Левин Д.Ю. и др. Особенности течения ОРВИ и гриппа A/H1N1/2009 у беременных. Инфекц. бол. 2011; 9 (2): 89-92.
  4. Горелов А.В., Плоскирева А.А., Дорошина Е.А. и др. Норовирусная инфекция на современном этапе: клинические проявления и терапевтические подходы. Инфекц. бол. 2011; 9 (2): 100-105.
  5. Сагалова О.И. Клинико-иммунологическая характеристика кишечных инфекций вирусной этиологии у взрослых. Автореф. дис.. д-ра мед. наук. М., 2010. 40 с.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies